Cargando…
Amyloid-Beta Peptides and Activated Astroglia Impairs Proliferation of Nerve Growth Factor Releasing Cells In Vitro: Implication for Encapsulated Cell Biodelivery-Mediated AD Therapy
Alzheimer’s disease (AD) treatment is constrained due to the inability of peripherally administered therapeutic molecules to cross the blood–brain barrier. Encapsulated cell biodelivery (ECB) devices, a tissue-targeted approach for local drug release, was previously optimized for human mature nerve...
Autores principales: | Mitra, Sumonto, Turchetto, Silvia, Van Os, Winant, Wahlberg, Lars U., Linderoth, Bengt, Behbahani, Homira, Eriksdotter, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616486/ https://www.ncbi.nlm.nih.gov/pubmed/34831056 http://dx.doi.org/10.3390/cells10112834 |
Ejemplares similares
-
Microglia Impairs Proliferation and Induces Senescence In-Vitro in NGF Releasing Cells Used in Encapsulated Cell Biodelivery for Alzheimer’s Disease Therapy
por: Mitra, Sumonto, et al.
Publicado: (2022) -
Feasibility and therapeutical potential of local intracerebral encapsulated cell biodelivery of BDNF to App(NL−G−F) knock-in Alzheimer mice
por: Tambaro, Simone, et al.
Publicado: (2023) -
Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF
por: Mitra, Sumonto, et al.
Publicado: (2019) -
Fast Alpha Activity in EEG of Patients With Alzheimer’s Disease Is Paralleled by Changes in Cognition and Cholinergic Markers During Encapsulated Cell Biodelivery of Nerve Growth Factor
por: Eyjolfsdottir, Helga, et al.
Publicado: (2022) -
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device
por: Eyjolfsdottir, Helga, et al.
Publicado: (2016)